Effects of vedolizumab, adalimumab and infliximab on biliary inflammation in individuals with primary sclerosing cholangitis and inflammatory bowel disease

Vedolizumab in patients with concurrent primary sclerosing cholangitis and inflammatory bowel disease does not improve liver biochemistry but is safe and effective for the bowel disease

(2018) B. Christensen et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Lack of efficacy of infliximab in the treatment of primary sclerosing cholangitis in inflammatory bowel diseases in childhood

(2017) Sabrina Cardile et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Update on anti-tumor necrosis factor agents and other new drugs for inflammatory bowel disease

(2017) Benjamin L Cohen et al.   BMJ-British Medical Journal

Update on anti-tumor necrosis factor agents and other new drugs for inflammatory bowel disease

(2017) Benjamin L Cohen et al.   BMJ-British Medical Journal

Primary sclerosing cholangitis associated with inflammatory bowel disease

(2016) Irene Franceschet et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

T-Cell Trafficking and Anti-Adhesion Strategies in Inflammatory Bowel Disease: Current and Future Prospects

(2014) Mahmoud H. Mosli et al.   DRUGS

Meta-analysis: ursodeoxycholic acid for primary sclerosing cholangitis

(2011) C. K. Triantos et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Alkaline phosphatase normalization is associated with better prognosis in primary sclerosing cholangitis

(2011) Peter P. Stanich et al.   DIGESTIVE AND LIVER DISEASE

Cell-specific effects of TNF-α and IL-1β on alkaline phosphatase: implication for syndesmophyte formation and vascular calcification

(2011) Philippe Lencel et al.   LABORATORY INVESTIGATION

TNF-α stimulates alkaline phosphatase and mineralization through PPARγ inhibition in human osteoblasts

(2010) P. Lencel et al.   BONE

Diagnosis and management of primary sclerosing cholangitis

(2009) Roger Chapman et al.   HEPATOLOGY

A Double-blind, Placebo-controlled, Randomized Study of Infliximab in Primary Sclerosing Cholangitis

(2008) Daan W. Hommes et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY